Emtricitabine
Chemical Structure Depiction of
Emtricitabine
Emtricitabine
Compound characteristics
| Compound ID: | CE04-8997 |
| Compound Name: | Emtricitabine |
| Molecular Weight: | 247.24 |
| Molecular Formula: | C8 H10 F N3 O3 S |
| CAS Number: | 143491-57-0 |
| Smiles: | C([C@@H]1O[C@@H](CS1)N1C=C(C(N)=NC1=O)F)O |
| InChI Key: | XQSPYNMVSIKCOC-PHDIDXHHSA-N |
| Short Description: | Emtricitabine (FTC) (FTC), a nucleoside reverse transcriptase inhibitor, exhibits inhibition activity against human immunodeficiency virus (HIV) and hepatitis B virus. |
| Pathway: | Proteases/Proteasome|||Microbiology/Virology |
| Target: | HIV Protease|||Reverse Transcriptase |
| Type of molecule: | FDA Approved/Clinical |
| Alias: | BW1592 , Emtriva , FTC |
| Stock amount: | 1008602 |